Efficacy and safety of AAE581 in postmenopausal women with osteopenia/osteoporosis
Phase of Trial: Phase II
Latest Information Update: 19 Aug 2016
At a glance
- Drugs Balicatib (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 01 Nov 2011 Actual end date (1 Dec 2005) added as reported by ClinicalTrials.gov.
- 02 Jul 2007 Status changed from in progress to completed.